Inactive Instrument

Diamond Wellness Holdings, Inc.

POTN

US7376362098

Potnetwork Holdings, Inc. Reports Audited Revenue Results for the Year 2018

April 11, 2019 at 08:00 am EDT

PotNetwork Holdings, Inc. released their fully audited financial statement which shows that the company has made $25 million in revenue over the course of 2018, a 78% increase compared to POTN’s performance in 2017.

Latest news about Diamond Wellness Holdings, Inc.

Diamond Wellness Holdings, Inc. Announces Resignation of Pooja Bhandari-Lamba as Chief Financial Officer	22-12-02	CI
Diamond Wellness Holdings, Inc. Announces Appointment of Rajeswari Murugan as Member of the Board of Directors	22-08-30	CI
PotNetwork Holdings, Inc. Announces Board Appointments	22-02-01	CI
Potnetwork Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-09-28	CI
Potnetwork Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-20	CI
Potnetwork Holdings, Inc. Appoints Kyle L. Pritz as VP of Product Development	20-11-19	CI
PotNetwork Holdings, Inc. Appoints Lee Lefkowitz as New Chief Executive Officer	20-10-27	CI
PotNetwork Holdings, Inc. Appoints Lee Lefkowitz as President and Director	20-10-27	CI
Potnetwork Holdings, Inc. Announces Kevin Hagen Resigned as Chief Executive Officer	20-10-27	CI
Potnetwork Holdings, Inc. Announces Resignation of Kevin Hagen	20-10-27	CI
Potnetwork Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-09-08	CI
Potnetwork Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-07-23	CI
PotNetwork Holdings, Inc. Excites CBD Industry with Launch of Private Label CBD Lab at MJBizCon, Las Vegas, December 11 13	19-12-19	CI
Potnetwork Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-18	CI
PotNetwork Holdings, Inc. Announces Board Changes	19-09-16	CI
Potnetwork Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-19	CI
Potnetwork Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-05-09	CI
PotNetwork Holdings, Inc. Provides Revenues Guidance for the Year 2019	19-05-02	CI
Potnetwork Holdings, Inc. Reports Audited Revenue Results for the Year 2018	19-04-11	CI
PotNetwork Holdings, Inc.’s Diamond CBD Hits The Road With New Fleet of Mobile Sales Vans	18-11-13	CI
PotNetwork Holdings, Inc.’s Diamond CBD Announces Plan to Sell Products in Shopping Malls Across America	18-11-08	CI
PotNetwork Holdings, Inc Announces Executive Changes	18-10-25	CI
PotNetwork Holdings Inc. Reports Revenue Results for the Third Quarter and Nine Months of 2018	18-10-18	CI
PotNetwork Holdings, Inc Reports Unaudited Revenue Results for the First Half Ended June 30, 2018	18-08-15	CI
PotNetwork Holding, Inc. Reports Sales Results for the Month of April 2018	18-05-15	CI

Chart Diamond Wellness Holdings, Inc.

Duration

Period

More charts

Company Profile

PotNetwork Holdings, Inc. is a holding company, which is focused on the cannabis industry and related verticals. The Company's primary business is conducted through its subsidiary, First Capital Venture Co., whose wholly owned subsidiary, CBD, LLC, does business under the trade style, Diamond CBD and is engaged in the development and sales of hemp-derived cannabidiol (CBD) oil containing products, which contain Full Spectrum CBD, Broad Spectrum CBD, or CBD Isolate. It offers various products that are marketed under several brand names, including Diamond CBD, Chill, Relax, MediPets and Meds BioTech label, as well as several others. The Company focused distribution on market segments receptive to CBD products, such as vape shops, smoke shops and various countercultural focused retail outlets. under its various brand names, Diamond CBD offers products sold directly to consumers over its Website, www.diamondcbd.com, and through distribution network of distributors and resellers.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+34.00%	664B
NOVO NORDISK A/S	+29.29%	567B
JOHNSON & JOHNSON	-7.75%	354B
MERCK & CO., INC.	+18.53%	330B
ABBVIE INC.	+4.95%	286B
ASTRAZENECA PLC	+13.79%	234B
NOVARTIS AG	+4.93%	199B
ROCHE HOLDING AG	-9.78%	196B
AMGEN INC.	-4.89%	148B

Other Pharmaceuticals